Cell Therapy for Coronary Heart Disease

NCT00289822 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: intracoronary infusion of progenitor cells

Sponsor

Johann Wolfgang Goethe University Hospital